Top Markets
Coin of the day
Defence Therapeutics Inc. Defence Therapeutics Inc.

Defence Therapeutics Inc.

DTC
Pozycja w akcjach #28133
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Cena akcji
$0.37430781
Ostatnia synchronizacja: 2026-08-19
Kapitalizacja rynkowa
$28.37M
Zmiana (1 dzień)
2.00%
Zmiana (1 rok)
-13.46%
Kraj
CA
Handel Defence Therapeutics Inc. (DTC)

Kategoria

Historia ceny akcji dla Defence Therapeutics Inc. (DTC)
Najwyższa cena zamknięcia: $0.32 dnia 2026-08-01

Najniższa cena zamknięcia: $2.94 dnia 2021-05-01
Historia cen akcji firmy Defence Therapeutics Inc. od 2021 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -20.25%
2025 47.28%
2024 -78.72%
2023 11.75%
2022 -62.63%
2021 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$123.19 -13.26%
AU
$753.28 5.84%
CH